DETECT Notifiable Diseases

The DETECT (Decrease Epidemiological Threats with Environmental Controls and Testing), TEST (Take Epidemiological Specimens Today), and REPORT (Rules for Every Provider and Organization to Report on Time) or DTR Notifiable Diseases awareness campaign emphasizes different disease control actions needed to reduce the impact of Alabama's reportable diseases and create a robust notifiable disease system.

DETECT Notifiable Diseases involves surveillance, investigation, and recommendations for reportable diseases. Public health surveillance is the ongoing, systematic collection (i.e., reported by providers or electronic lab systems), analysis, interpretation, and dissemination of data about a health-related event to reduce morbidity and mortality and to improve health. Public health recommendations are given to stop the transmission and to prevent further disease in the population.

DETECT Education Resources

• To learn about the new Notifiable Diseases Rules effective 4/14/2024, request a free DTR CEU Program conducted by Infectious Diseases & Outbreaks District Investigators.
• Download the updated Notifiable Disease Rule Appendices for reference and to share with other reporters.
  • Appendix I - Reportable Diseases and Conditions (Healthcare Providers)
  • Appendix II and III - Reportable Laboratory Test Results and Submission of Clinical Materials (Laboratories) 

Below are the Alabama Notifiable Diseases and a link to basic information about each disease.

Immediate, Extremely Urgent Disease/Condition

(Notify ADPH within 4 hours of presumptive diagnosis)

• Anthrax, Human
• Botulism (Foodborne, Infant, Wound)
• Brucellosis
• Plague
• Poliomyelitis, paralytic
• Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV) disease
• Smallpox
• Tularemia
• Viral hemorrhagic fever
• Cases related to nuclear, biological, or chemical terroristic agents*

Immediate, Urgent Disease/Condition

(Notify ADPH within 24 hours of presumptive diagnosis)

• COVID-19 infection in congregate living facilities
• Diphtheria
• Haemophilus influenzae, invasive disease¹
• Hemolytic uremic syndrome (HUS), post-diarrheal
• Hepatitis A, including ALT
• Legionellosis
• Measles
• Meningococcal disease (Neisseria meningitidis)¹
• Novel influenza A virus (i.e., potential new strain)
• Pertussis
• Poliovirus infection, nonparalytic
• Rabies, human and animal
• Rubella
• Tuberculosis
• Typhoid fever
• Outbreaks of any kind
• Cases of potential public health importance²

Standard Notification Disease/Condition

(Notify ADPH within 3 days of diagnosis, unless otherwise noted)

• Acute Flaccid Myelitis
• Anaplasmosis
• Arboviral diseases (in addition to those listed)
• Babesiosis
• Birth Defects²
• Campylobacteriosis
• Chancroid
• Chlamydia trachomatis
• Cholera
• Coccidioidomycosis
• Cryptosporidiosis
• Cyclosporiasis
• Dengue
• E. coli, shiga-toxin producing (STEC)
• Ehrlichiosis
• Giardiasis
• Gonorrhea
• Hansen's disease (Leprosy)
• Hepatitis B, C, and other viral (acute only and with associated ALTs)
• HIV (including asymptomatic infection, AIDS, CD4 counts and viral load)
• Influenza-associated pediatric deaths
• Lead, all blood results
• Listeriosis¹
• Lyme disease
• Malaria
• Mumps
• Perinatal Hepatitis B & C
• Perinatal HIV exposure (<18 months of age)
• Primary amebic meningoencephalitis
• Q Fever
• Salmonellosis (including paratyphoid fever)
• Shigellosis
• Spotted Fever Rickettsiosis
• Staphylococcus aureus, Vancomycin-intermediate (VISA) and Vancomycin-resistant (VRSA)
• Streptococcus pneumoniae, invasive disease¹
• Syphilis
• Tetanus
• Trichinellosis (Trichinosis)
• Tuberculosis infection, latent
• Varicella
• Vibriosis
• Yellow fever
• Zika

Terroristic Agents = Select Agents and Toxins List

^* Designated Sexually Transmitted Diseases by the State Board of Health

¹ Detection from a normally sterile body site (e.g., blood, cerebrospinal fluid, or less commonly joint, pleural, or pericardial fluid)

² Reportable within 30 days of diagnosis or associated laboratory test